Susmed (4263) · InitiativeRestated
Strengthening the intellectual property base through the acquisition of an international patent for an app to treat insomnia
First written in FY2023-Q3. 1 of 2 entries say "Restated". Latest entry: FY2023.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Securing international patents for an insomnia disorder treatment appA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2023RestatedAnnual report
「For patents related to the app, in addition to those already granted in Japan, the United States, South Korea and Indonesia, the company received a decision to grant a patent in Europe, further strengthening its intellectual property base.」
The company continues to report the strengthening of its intellectual property base through granted patents and patent grants, including in Europe, for the insomnia treatment app. - FY2023-Q3First statedAnnual report
「Patents related to the app had been granted in Japan, the United States, South Korea and Indonesia. In addition, the company received a decision to grant a patent from the European Patent Office, further strengthening its intellectual property base.」
For the insomnia treatment app, the company reported the decision to grant a patent by the European Patent Office, in addition to patents granted in Japan, the United States, South Korea and Indonesia, as progress in strengthening its intellectual property base.